DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Randomized comparison of fluorouracil plus cisplatin vs. cisplatin as an adjunct to radiation therapy in stage IIB-IVA squamous cell carcinoma of the cervix: pilot study.

Author(s): Sukhaboon J, Porapakkhan P, Penpattanagul S

Affiliation(s): Department ofTherapeutic Radiology, Udonthani Cancer Center, Udon Thani, Thailand. Fodjiji@yahoo.com

Publication date & source: 2009-08, J Med Assoc Thai., 92(8):1072-6.

Publication type: Comparative Study; Randomized Controlled Trial

OBJECTIVE: To compare the efficacy and toxicity of pelvic radiotherapy with concomitant cisplatin plus fluorouracil versus cisplatin alone in patients with locally advanced squamous cell cervical cancer. MATERIAL AND METHOD: Twenty women with squamous cell cervical cancer were randomly assigned to receive ether standard whole pelvic radiotherapy with concurrent cisplatin and fluorouracil infusion every 4 weeks or the same radiotherapy with concurrent cisplatin every 1 week. The primary endpoint was the response rate. RESULTS: All patients in cisplatin plus fluorouracil regimen and in cisplatin regimen had complete response. In cisplatin group there was higher frequencies of adverse hematologic effects. Grade 3 or 4 neutropenia occurred in 10% of the cisplatin plus fluorouracil group and in 40% of the cisplatin group (p = 0.049). CONCLUSION: No difference was found in the response rate, but higher frequencies of hemotological adverse effects in the cisplatin group.

Page last updated: 2010-10-05

-- advertisement -- The American Red Cross
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017